While thousands are turning to Mounjaro and other GLP-1s to help them with their diabetes and weight loss, many of them are suffering severe, unexpected complications
We build relationships with each of our patients because we understand that a personal relationship helps patients feel more comfortable communicating their concerns, questions, and needs much easier
[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Li B., Umapathy A., Tran L.U., Donaldson P.J., Lim J.C
Results of this study suggest a modest increase in the risk of NAION among individuals with type 2 diabetes associated with semaglutide use, smaller than that previously reported, and warranting further investigation into the clinical implications of this association, the study concluded
Domperidone may be used at the lowest effective dose for the shortest possible duration in selected patients without cardiac risk factors, following MHRA restrictions